Overview
McDermott is featured in this Global Legal Chronicle article for representing Ampersand Capital Partners in its business combination of Biosynth Carbosynth and Vivitide, Inc.
The cross-border US, UK, Germany and Belgium team was led by Kristian Werling, Lindsey Reighard and Calum Thom with corporate support from John Prinzivalli, Simon Margesson, Christian Marzlin, Michael Cziesla, Deniz Tschammler, Lea Hachmeister, Lisa Schickling, Jana Grieb, Gudrun Germakowski and Lukas Deutzmann. Hendrik Viaene led the global regulatory approval process with support from Carina Kant and Anja Bertrand. Global tax structuring was led by Michael Bruno with support from Alejandro Ruiz and the finance team was led by Anh Lee with support from Libby Jacobson.